Drug Shortage Report for AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Report ID | 234906 |
Drug Identification Number | 02470780 |
Brand name | AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN |
Common or Proper name | AA-Lansoprazole-Amoxicillin-Clarithromycin |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE |
Strength(s) | 500MG 500MG 30MG |
Dosage form(s) | TABLET CAPSULE KIT CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 56Bls |
ATC code | A02BD |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-08-07 |
Estimated end date | 2025-02-03 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-28 |
Company comments | Short-dated inventory available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-11-28 | French | Compare |
v5 | 2024-11-28 | English | Compare |
v4 | 2024-09-04 | French | Compare |
v3 | 2024-09-04 | English | Compare |
v2 | 2024-08-08 | French | Compare |
v1 | 2024-08-08 | English | Compare |
Showing 1 to 6 of 6